Because ivermectin is being used to treat COVID-19 with insufficient evidence, the
investigator conducted a randomized clinical trial to investigate the efficacy and safety of
ivermectin in comparison to hydroxychloroquine and placebo in severe COVID-19 patients. The
study was conducted in Shebin-Elkom teaching hospital and recruited patients from December 6,
2020, to January 31, 2021.